Kraig Biocraft Laboratories, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $98.8M
- Price
- $0.08983
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.93%
- Volume
- 267.9K
About
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company’s products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; military and police for its ballistic protection; and geotextiles, safe and protective clothing, textiles used in transportation and buildings, and functional and sportive textiles. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
Quick stats
Shares outstanding1.1B
Computed float1.0B
Float / shares95.2%
Key info
SectorIndustrials
IndustryManufacturing - Textiles
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001413119
Websitehttps://www.kraiglabs.com
AI Summary
AI-generated1/29
minorbullishoperations update
Indistinguishable From Magic: How Kraig Labs Brought Spider Silk into Reality
Kraig Biocraft Laboratories shipped its first commercial order of recombinant spider silk yarn to a globally recognized performance sports brand on September 29, per this recap.
The company's three Vietnam production centers are running staggered schedules, with silk production growing more than 30% through the rainy season, and all planned Project Atlas transgenes have been integrated into living silkworm hosts.
Note this is a paid editorial published by Wall Street PR, which is contracted by Kraig Labs for cash and restricted shares — it is promotional third-party content, not an issuer-issued release with new material disclosures.
Red flags
- paid promotional editorial — publisher receives cash and restricted shares from the subject company
- all headline milestones previously announced; no new information disclosed
- customer name and program details confidential